Background: Earlier studies revealed that 10%-50% of patients reported remaining complaints after treatment for Lyme neuroborreliosis (LNB). The aim of our study was to assess symptoms and quality of life in patients with diagnosed and treated LNB and to compare them with findings in the general population.
Methods: Adults with LNB receiving adequate antibiotics were included between 2015 and 2021 in 2 tertiary hospitals.